Total Payments
$20,986
2024 Payments
$1,408
Companies
70
Transactions
1,171
Medicare Patients
3,251
Medicare Billing
$834,904
Payment Breakdown by Category
Food & Beverage$20,229 (96.4%)
Education$393.13 (1.9%)
Other$363.54 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,229 | 1,128 | 96.4% |
| Education | $393.13 | 20 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $363.54 | 23 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,680 | 112 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,480 | 89 | $0 (2024) |
| UCB, Inc. | $1,098 | 46 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $957.18 | 56 | $0 (2024) |
| Allergan, Inc. | $925.19 | 59 | $0 (2022) |
| GENZYME CORPORATION | $908.99 | 44 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $857.04 | 72 | $0 (2022) |
| Biogen, Inc. | $855.50 | 49 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $847.02 | 49 | $0 (2022) |
| Amgen Inc. | $690.47 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,408 | 68 | ACADIA Pharmaceuticals Inc ($202.56) |
| 2023 | $2,086 | 116 | AbbVie Inc. ($381.64) |
| 2022 | $3,303 | 163 | ABBVIE INC. ($537.31) |
| 2021 | $4,352 | 229 | AbbVie Inc. ($497.27) |
| 2020 | $2,779 | 159 | Allergan, Inc. ($426.96) |
| 2019 | $2,455 | 152 | GENZYME CORPORATION ($316.80) |
| 2018 | $2,334 | 151 | Teva Pharmaceuticals USA, Inc. ($313.30) |
| 2017 | $2,270 | 133 | Teva Pharmaceuticals USA, Inc. ($369.47) |
All Payment Transactions
1,171 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Neuroscience | ||||||
| 08/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: PAIN | ||||||
| 07/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/26/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $33.88 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/23/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Neuroscience | ||||||
| 07/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Neurology | ||||||
| 07/16/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Adenosine A2A Receptors | ||||||
| 07/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: PAIN | ||||||
| 07/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: AMANTADINE | ||||||
| 06/29/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Neuroscience | ||||||
| 06/25/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: NEUROLOGY | ||||||
| 06/24/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Neurology | ||||||
| 06/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| 06/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: PAIN | ||||||
| 06/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Neurology | ||||||
| 05/31/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Immunology | ||||||
| 05/29/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.45 | General |
| 05/28/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 781 | 33,321 | $633,240 | $282,183 |
| 2022 | 12 | 862 | 17,931 | $456,625 | $206,924 |
| 2021 | 13 | 785 | 13,095 | $413,829 | $179,184 |
| 2020 | 15 | 823 | 13,779 | $434,695 | $166,613 |
Total Patients
3,251
Total Services
78,126
Medicare Billing
$834,904
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 51 | 32,200 | $225,400 | $159,222 | 70.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 256 | 399 | $145,635 | $52,052 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 363 | $107,085 | $33,205 | 31.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 29 | 96 | $72,000 | $11,678 | 16.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $28,800 | $10,385 | 36.1% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 15 | 48 | $24,000 | $7,548 | 31.4% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 17 | 53 | $10,335 | $3,392 | 32.8% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 15 | 37 | $10,710 | $2,256 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 17 | $3,825 | $954.30 | 24.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 32 | 35 | $3,500 | $905.28 | 25.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 13 | 13 | $1,950 | $586.82 | 30.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 50 | 16,780 | $117,460 | $81,096 | 69.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 250 | 327 | $99,795 | $44,861 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 279 | 417 | $102,120 | $38,309 | 37.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 119 | 119 | $47,600 | $18,862 | 39.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 24 | 51 | $25,500 | $8,176 | 32.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 24 | 30 | $22,500 | $3,808 | 16.9% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2022 | 16 | 73 | $15,960 | $3,697 | 23.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 24 | 50 | $9,750 | $3,428 | 35.2% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 11 | 17 | $6,800 | $2,004 | 29.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 23 | 24 | $3,840 | $1,132 | 29.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 19 | 20 | $3,000 | $935.41 | 31.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 23 | 23 | $2,300 | $616.62 | 26.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 23 | 12,000 | $84,000 | $57,152 | 68.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 315 | 481 | $117,845 | $45,026 | 38.2% |
About Dr. Michael Sorrell, M.D
Dr. Michael Sorrell, M.D is a Neurology healthcare provider based in Springfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528069887.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Sorrell, M.D has received a total of $20,986 in payments from pharmaceutical and medical device companies, with $1,408 received in 2024. These payments were reported across 1,171 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($20,229).
As a Medicare-enrolled provider, Sorrell has provided services to 3,251 Medicare beneficiaries, totaling 78,126 services with total Medicare billing of $834,904. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Springfield, MA
- Active Since 08/09/2005
- Last Updated 08/19/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1528069887
Products in Payments
- Briviact (Drug) $976.78
- NUPLAZID (Drug) $957.18
- BOTOX (Biological) $809.80
- UBRELVY (Drug) $774.22
- NURTEC ODT (Drug) $731.07
- Aimovig (Biological) $612.65
- QULIPTA (Drug) $607.04
- AUBAGIO (Drug) $554.63
- TROKENDI XR (Drug) $512.58
- Hizentra (Biological) $490.09
- EMGALITY (Drug) $478.19
- TYSABRI (Biological) $478.06
- RYTARY (Drug) $449.22
- COPAXONE (Drug) $422.98
- AJOVY (Biological) $388.09
- Gamunex-C (Biological) $375.43
- INGREZZA (Drug) $335.58
- ACTHAR (Biological) $325.35
- OXTELLAR XR (Drug) $309.18
- LEMTRADA (Drug) $298.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Springfield
David Clark, Do, DO
Neurology — Payments: $1.1M
Neurology $1.1M
Raymond Englander, Md, MD
Neurology — Payments: $167,481
Neurology $167,481
Dr. Jenifer Zhai, Md, MD
Neurology — Payments: $121,314
Neurology $121,314
Cecile Becker, M.d, M.D
Neurology — Payments: $78,042
Neurology $78,042
Jennifer Lynch, Md, MD
Neurology — Payments: $73,454
Neurology $73,454
Jayant Acharya, Md, MD
Neurology — Payments: $56,046
Neurology $56,046